Trials / Unknown
UnknownNCT03780998
Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases
Effects of Sodium Pentaborat Based Gel on Perianal Benign Diseases. Prospective Clinical Trial
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- SB Istanbul Education and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
New produced and patented sodium pantaborat based gel will be use for treatment of benign perianal diseases (hemooroidal disease, anal fissura anda perianal fistula)
Detailed description
Prospective randomised clinical trial planned. Older than 18 years old perianal benign diseases (grade 1 and 2 hemorroidal disease, anal fissura, uncomplicated simple perianal fistula) cases without malign tumour, cronic colorectal disases, and routine used of vasoactive medication cases were entered the study. Younger than 18 years old, diagnosed any malign tumor and/or cronic colorectal disaeses, routine used of vasoact,ve mediaction cases were exclused of the study. Group-1 (n: 50): Healthy cases (control group) Group-2 (n:50): Grade 1 hemorroidal disease cases Group-3 (n:50): Grade 2 hemorroidal disease cases Group-4 (n:50): Anal fissure cases Group-5 (n:50): Uncomplicated, simple perianal fistula cases
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Life7 | Life7 will used on the perianal skin with finger tips |
Timeline
- Start date
- 2019-01-01
- Primary completion
- 2019-01-01
- Completion
- 2020-01-01
- First posted
- 2018-12-19
- Last updated
- 2018-12-21
Source: ClinicalTrials.gov record NCT03780998. Inclusion in this directory is not an endorsement.